“As we’ve begun to work with some of our current partners on their initial COVID-19 trials, we realized that we have an opportunity to materially impact fighting this virus. So, in response to the global outbreak of the COVID-19 pandemic, we want to ensure all researchers working to contribute to a vaccine or effective treatment have access to a platform that can facilitate virtual teams collaboration, management, and execution of their COVID-19 clinical trials,” said Scott DeMell, VP Sales at Datatrak. “As our industry comes together to fight COVID-19, they need ways to streamline data collection and facilitate workflows for their studies,” said Jim Bob Ward, CEO and President of Datatrak. “Our ability to collect any data source improves the clinical collaboration, and when coupled with the use of our advanced reporting options, we hope to accelerate bringing successful solutions to people in need.” For additional information, please contact us at email@example.com or visit www.datatrak.com, and find out how we can get your COVID-19 study designed, validated and deployed quickly. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies.
- Data Management and Acquisition
- ERP & Process Management
- Enterprise Resource Planning (ERP)
- Learning Management Systems (LMS)
- Business Intelligence